Biozeal Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 4.00 Cr
as on 06-07-2024
- Paid Up Capital ₹ 3.49 Cr
as on 06-07-2024
- Company Age 14 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.80 M
as on 06-07-2024
- Revenue -40.81%
(FY 2021)
- Profit 75.22%
(FY 2021)
- Ebitda -335.41%
(FY 2021)
- Net Worth -43.03%
(FY 2021)
- Total Assets -19.12%
(FY 2021)
About Biozeal Lifesciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 Cr and a paid-up capital of Rs 3.49 Cr.
The company currently has active open charges totaling ₹1.80 M.
Pinkesh Solanki and Asif Tak serve as directors at the Company.
- CIN/LLPIN
U24239MH2010PTC199145
- Company No.
199145
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Jan 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Biozeal Lifesciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pinkesh Solanki  | Director | 01-Apr-2017 | Current |
| Asif Tak | Director | 21-Jan-2010 | Current |
Financial Performance of Biozeal Lifesciences.
Biozeal Lifesciences Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 40.81% decrease. The company also saw a substantial improvement in profitability, with a 75.22% increase in profit. The company's net worth observed a substantial decline by a decrease of 43.03%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biozeal Lifesciences?
In 2021, Biozeal Lifesciences had a promoter holding of 97.03% and a public holding of 2.97%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Auffullen Healthcare Private LimitedActive 7 years 7 monthsPinkesh Solanki and Asif Tak are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 23 Apr 2020 | ₹1.80 M | Open |
How Many Employees Work at Biozeal Lifesciences?
Unlock and access historical data on people associated with Biozeal Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biozeal Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biozeal Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
